Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 2/20 | 0.34 |
| ▸ | ASH1L | Q9NR48 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR5A | P47898 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23119059 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22172808 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22172908 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22173361 | 0.99 | TSPO (0.40) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22172807 | 0.99 | TSPO (0.40) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22173035 | 0.98 | ATM (0.42) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22172822 | 0.98 | ATM (0.42) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22173224 | 0.98 | ATM (0.42) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22173028 | 0.98 | ATM (0.42) | KDM4EATML3MBTL1TSPOALDH1A1 | |
| SCHEMBL22173360 | 0.98 | ATM (0.42) | KDM4EATML3MBTL1TSPOALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-11542252-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-01-03 | — | — | US | disclosed |
| US-20200207739-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542252-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | KDM4E 3931/4885ATM 1887/4885L3MBTL1 175/4885 |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | KDM4E 3931/4885ATM 1887/4885L3MBTL1 175/4885 |
| US-20200207739-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | KDM4E 3931/4885ATM 1887/4885L3MBTL1 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.